✦ LIBER ✦

Discovery of Potent and Selective Agonists for the Free Fatty Acid Receptor 1 (FFA 1 /GPR40), a Potential Target for the Treatment of Type II Diabetes

✍ Scribed by Christiansen, Elisabeth; Urban, Christian; Merten, Nicole; Liebscher, Kathrin; Karlsen, Kasper K.; Hamacher, Alexandra; Spinrath, Andreas; Bond, Andrew D.; Drewke, Christel; Ullrich, Susanne; Kassack, Matthias U.; Kostenis, Evi; Ulven, Trond

Book ID: 120634292
Publisher: American Chemical Society
Year: 2008
Tongue: English
Weight: 177 KB
Volume: 51
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm8010178

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discovery of TUG-770: A Highly Potent Fr

Discovery of TUG-770: A Highly Potent Free Fatty Acid Receptor 1 (FFA1/GPR40) Agonist for Treatment of Type 2 Diabetes

✍ Christiansen, Elisabeth; Hansen, Steffen V. F.; Urban, Christian; Hudson, Brian 📂 Article 📅 2013 🏛 American Chemical Society 🌐 English ⚖ 918 KB

Discovery of Phenylpropanoic Acid Deriva

Discovery of Phenylpropanoic Acid Derivatives Containing Polar Functionalities as Potent and Orally Bioavailable G Protein-Coupled Receptor 40 Agonists for the Treatment of Type 2 Diabetes

✍ Mikami, Satoshi; Kitamura, Shuji; Negoro, Nobuyuki; Sasaki, Shinobu; Suzuki, Mas 📂 Article 📅 2012 🏛 American Chemical Society 🌐 English ⚖ 689 KB

M1736 Blockade of Angiotensin II Type 1

M1736 Blockade of Angiotensin II Type 1 Receptor Reduces Hepatocellular Lipid Accumulation in An In Vitro Model of Steatosis: A Potential Implication for the Treatment of Non-Alcoholic Fatty Liver Disease

✍ Kanno, Keishi; Ikuta, Takuya; Matsuda, Sosuke; Kishikawa, Nobusuke; Tazuma, Susu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Erratum to “RBx-0597, a potent, selectiv

Erratum to “RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetes” [European Journal of Pharmacology 652 (1–3) (2011) 157–163]

✍ Shuchita Singh; Subhasis Roy; Sachin Sethi; Biju Benjamin; Sindhuja Sundaram; Vi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Correction to Discovery of (2 R )-2-(3-{

Correction to Discovery of (2 R )-2-(3-{3-[(4-Methoxyphenyl)carbonyl]-2-methyl-6-(trifluoromethoxy)-1 H -indol-1-yl}phenoxy)butanoic Acid (MK-0533): A Novel Selective Peroxisome Proliferator-Activated Receptor γ Modulator for the Treatment of Type 2 Diabetes Mellitus with a Reduced Potential to Increase Plasma and Extracellular Fluid Volume

✍ Acton, John J.; Akiyama, Taro E.; Chang, Ching H.; Colwell, Lawrence; Debenham, 📂 Article 📅 2013 🏛 American Chemical Society 🌐 English ⚖ 112 KB

8-(3-(R)-Aminopiperidin-1-yl)-7-but-2-yn

8-(3-(R)-Aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a Highly Potent, Selective, Long-Acting, and Orally Bioavailable DPP-4 Inhibitor for the Treatment of Type 2 Diabetes†

✍ Eckhardt, Matthias; Langkopf, Elke; Mark, Michael; Tadayyon, Moh; Thomas, Leo; N 📂 Article 📅 2007 🏛 American Chemical Society 🌐 English ⚖ 235 KB